Market Overview

Halozyme Therapeutics, Inc. (NASDAQ: HALO)

16.32 -0.10 (-0.64%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2020
After-Hours
EPS:
REV:
0.01
56.949M



Q4 2019
After-Hours
EPS:
REV:
-0.01
60.232M



Q3 2019
After-Hours
EPS:
REV:
-0.19
25.556M



Q2 2019
After-Hours
EPS:
REV:
-0.16
35.202M



Q1 2019
After-Hours
EPS:
REV:
-0.19
30.872M
0.01
67.8M
0.01
56.949M
0%
-16%
Q4 2018
After-Hours
EPS:
REV:
0.85
189.564M
-0.03
59.94M
-0.01
60.232M
-66.67%
0.49%
Q3 2018
After-Hours
EPS:
REV:
0.02
63.731M
-0.23
30.42M
-0.19
25.556M
-17.39%
-15.99%
Q2 2018
After-Hours
EPS:
REV:
-0.23
33.75M
-0.22
30.09M
-0.16
35.202M
-27.27%
16.99%
Q1 2018
After-Hours
EPS:
REV:
-0.26
29.568M
-0.22
31.43M
-0.19
30.872M
-13.64%
-1.78%
Q4 2017
After-Hours
EPS:
REV:
-0.21
39.003M

0.85
189.564M

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!